| Literature DB >> 31594437 |
Jinwei Pang1, John H Zhang2, Yong Jiang1.
Abstract
Successful recanalization of the occluded vessel as early as possible has been widely accepted as the key principle of acute ischemic stroke (AIS) treatment. Unfortunately, for many years, the vast majority of AIS patients were prevented from receiving effective recanalization therapy because of a narrow therapeutic window. Recently, a series of inspiring clinical trials have indicated that more patients may benefit from delayed recanalization during an expanded therapeutic window, even up to 24 h after symptom onset. However, could potentially salvageable brain tissue (penumbra) in patients who do not receive medication within 24 h still possible to be saved?Entities:
Keywords: Acute ischemic stroke; clinical trials; delayed recanalization; penumbra; therapeutic window
Mesh:
Year: 2019 PMID: 31594437 PMCID: PMC6893989 DOI: 10.1177/0271678X19881449
Source DB: PubMed Journal: J Cereb Blood Flow Metab ISSN: 0271-678X Impact factor: 6.200